FinnGen: an expedition into genomics and medicine

FinnGen is a research project in genomics and personalized medicine. It is large public-private partnership that has collected and analysed genome and health data from 500,000 Finnish biobank donors to understand the genetic basis of diseases. FinnGen is now expanding into understanding the progression and biological mechanisms of diseases. FinnGen provides a world-class resource for further breakthroughs in disease prevention, diagnosis, and treatment and a outlook into our genetic make-up.

Our first laboratory value GWAS results have been released!

Study cohort

FinnGen has collected and correlated genome and longitudinal health data of more than 500 000 Finns, which is almost 10% of the Finnish population.

Participation

The FinnGen study utilises samples collected by a nationwide network of Finnish biobanks. The study is based on combining genome information with digital health care data from national health registries.

Everybody benefits

The genome data produced during the project will be owned by the Finnish biobanks, and remain available for researcher purposes. The medical breakthroughs that arise from the project will eventually benefit health care systems and patients globally.

Collaboration is the key

The collaborative nature of the FinnGen research project is exceptional compared to many other studies. The study involves all the same actors as drug development. With this open cooperation, we hope to speed up the emergence of new innovations.

Data freeze 12 results and summary statistics now available!

Results can be browsed online using the FinnGen web browser and the summary statistics downloaded

This data freeze consists of >500,000 individuals, more than 21.3 M variants and 2,500 health endpoints. To get more information about how to access the results and summary statistics, please follow this link:

Access results

New accessible and engaging FinnGen communication resource available!

Scroll through the website to learn about the FinnGen project, its goals, processes and its impact in Finland and around the world.

Can you imagine what genetic diversity looks like in large populations or visualise where genes are located on chromosomes in relation to each other? We teamed up with Aalto University to produce a resource that uses data visualisation to tell the FinnGen story to a wider audience.

Enter the scrollytelling website

Screenshots from the scrollytelling website.

News

Alnylam Becomes Newest Partner in FinnGen Consortium

FinnGen is proud to welcome Alnylam Pharmaceuticals as its newest industry partner. As the 15th pharmaceutical company to join the public-private partnership, Alnylam brings world-leading expertise in RNA interference (RNAi) therapeutics to the consortium, further enriching the scientific and translational potential of the FinnGen study.

12.11.2025

Genes may predict suicide risk in depression

Depression in young adulthood has a stronger hereditary component and is associated with a higher risk of suicide attempts than depression that begins later in life, according to a new study published in Nature Genetics by researchers at Karolinska Institutet, among others.

A person wearing a hooded jacket and jeans stands alone on a metal railway bridge, facing away from the camera.

20.11.2025

Tweets by FinnGen_FI

FinnGen brings together the nation-wide network of Finnish biobanks.

Every Finn can be a part of the FinnGen study by giving a biobank consent.

Samples available

629 000

Samples needed by 2023: 520 000

Current data freeze

520 210

combined genotype and health registry data